Image

Observational Study on AI Accuracy in Diagnosing and Treating Failed or Painful Hip Arthroplasty

Observational Study on AI Accuracy in Diagnosing and Treating Failed or Painful Hip Arthroplasty

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

Primary Goal:

This study aims to evaluate the diagnostic and therapeutic accuracy of GPT-4 (an advanced AI language model) compared to three orthopedic surgeons with varying experience levels in cases of failed or painful total hip arthroplasty.

Key Research Questions:

Diagnostic Accuracy:

Does GPT-4 provide correct, partially correct, or incorrect diagnoses compared to human orthopaedic surgeons?

Diagnostic Completeness:

Are GPT-4's diagnostic suggestions complete, partially complete, or incomplete compared to those of orthopedic surgeons?

Treatment Accuracy:

Does GPT-4 recommend correct, partially correct, or incorrect treatments for failed hip arthroplasty?

Treatment Completeness:

Are GPT-4's treatment recommendations fully comprehensive, partially complete, or incomplete compared to those of orthopaedic surgeon?

Study Design:

Participants

20 anonymized patient cases (ages 18-80) with failed or painful hip arthroplasties, treated at IRCCS Istituto Ortopedico Rizzoli (Bologna, Italy) between 2004-2024.

Cases were selected based on clear diagnostic and treatment records (no ambiguous or incomplete data).

Comparison Groups:

GPT-4 (via ChatGPT interface)

Three orthopedic doctors (with different experience levels: resident, specialist, senior surgeon)

Method

Each case (clinical summary + X-ray image) is presented to GPT-4 and the three doctors.

They must provide a diagnosis and treatment recommendations.

Two independent evaluators (principal investigator + department head) blindly assess responses for correctness and completeness using a 3-point scale (0=wrong/incomplete, 2=correct/complete).

Statistical analysis compares GPT-4 vs. human performance.

Expected Outcomes:

Determine if AI can match or outperform doctors in diagnosing and treating hip arthroplasty failures.

Assess whether GPT-4 could serve as a supplementary tool in orthopedic decision-making.

Ethical & Privacy Considerations:

No real-time patient data is used-only anonymized past cases.

No personal/sensitive data is shared with OpenAI (GPT-4 is used via a standard web interface).

Study complies with GDPR, HIPAA, and ethical AI guidelines.

Timeline

Study duration: ~8 months (from ethics approval to final analysis).

Results will be published regardless of outcome.

Why This Study Matters:

First study evaluating GPT-4's role in complex orthopedic diagnostics.

Could influence future AI-assisted clinical decision-making in joint replacement surgeries.

Eligibility

Inclusion Criteria:

  • Adults (≥18 and ≤80 years old).
  • Documented painful or failed total hip arthroplasty requiring clinical/radiological evaluation (2004-2024).
  • Complete pre-operative clinical history, imaging (X-ray/tomography), and surgical reports.
  • Clear diagnosis of failure mode (e.g., aseptic loosening, infection, fracture, wear).
  • Treatment and outcomes fully documented in the institutional database.
  • "Exemplary" cases with minimal diagnostic ambiguity (per Engh/MusculoSkleletal Infection Society criteria, etc.).

Exclusion Criteria:

  • total hip arthroplasty with no documented failure/pain (well-functioning implants).
  • Incomplete clinical/radiological records (e.g., missing pre-operative imaging or surgical notes).
  • Complex/multifactorial failures (e.g., concurrent infection + loosening + fracture).
  • Radiographs/images non-interpretable (poor quality, missing views).
  • Cases with conflicting diagnoses/treatments in original records.

Study details
    Total Hip Arthroplasty (THA)

NCT07012577

Istituto Ortopedico Rizzoli

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.